youtube_live
Q3 2026 earnings • released • EPS beat +11.45% • Revenue beat +3.01%
See resultschevron_right
AMG:ETR
Amgen Inc
€430.90
arrow_upward
+1.75%(+7.40) 1D
Nov 5, 12:32:27 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMG...
Open
€423.95
High
€430.90
Low
€423.95
Mkt. cap
258.68B
Avg. vol.
510.00
Volume
156.00
52-wk high
€438.75
52-wk low
€263.60
No. of employees
32K
Open
€423.95
High
€430.90
Low
€423.95
Mkt. cap
258.68B
Avg. vol.
510.00
Volume
156.00
52-wk high
€438.75
52-wk low
€263.60
No. of employees
32K
News stories
From web sources and news partners
MarketWatch
·
15 hours ago
Amgen Inc. stock underperforms Wednesday when compared to competitors despite daily gains
Benzinga
·
18 hours ago
Amgen Analyst Likes Diversified Business, Remains Patient Until MariTide Obesity Data
TOKENPOST
·
19 hours ago
Amgen Raises 2026 Revenue Outlook to $38.9 Billion to $39.7 Billion
TradingView
·
19 hours ago
Amgen Stocks Rise 5.91% as Higher Guidance Narrows the Remaining Earnings Test
Profile
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
About Amgen Inc
CEORobert A. Bradway
Employees31.5K
Founded1980
HeadquartersThousand Oaks, California, United States
SectorBiotechnology
Industry-
Websiteamgen.com